{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:35:57Z","timestamp":1782862557174,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00415-025-13208-8","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T08:57:55Z","timestamp":1751273875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Equity in neuromuscular research: a 20-year analysis of race, ethnicity, sex, and age representation"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4370-4190","authenticated-orcid":false,"given":"Lorenzo","family":"Fontanelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3273-5362","authenticated-orcid":false,"given":"Gabriele","family":"Vadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-6836","authenticated-orcid":false,"given":"Gabriele","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4874-8830","authenticated-orcid":false,"given":"Andrea","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6142-2384","authenticated-orcid":false,"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"13208_CR1","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1001\/jama.2022.9083","volume":"327","author":"K Bibbins-Domingo","year":"2022","unstructured":"Bibbins-Domingo K, Helman A, Dzau VJ (2022) The imperative for diversity and inclusion in clinical trials and health research participation. JAMA 327:2283\u20132284","journal-title":"JAMA"},{"key":"13208_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/d41586-018-05049-5","volume":"557","author":"TC Knepper","year":"2018","unstructured":"Knepper TC, McLeod HL (2018) When will clinical trials finally reflect diversity? Nature 557:157\u2013159","journal-title":"Nature"},{"key":"13208_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209730","author":"C Tur","year":"2024","unstructured":"Tur C, Carvajal R, Otero-Romero S, Tintore M (2024) Generalizing the results of clinical trials if participants are not from diverse racial and ethnic groups. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000209730","journal-title":"Neurology"},{"key":"13208_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamaneurol.2020.5536","volume":"78","author":"N Rosendale","year":"2021","unstructured":"Rosendale N, Wong JO, Flatt JD, Whitaker E (2021) Sexual and gender minority health in neurology: a scoping review. JAMA Neurol 78:747\u2013754","journal-title":"JAMA Neurol"},{"key":"13208_CR5","doi-asserted-by":"publisher","first-page":"e1269","DOI":"10.1542\/peds.2011-3565","volume":"130","author":"SK Pasquali","year":"2012","unstructured":"Pasquali SK, Lam WK, Chiswell K, Kemper AR, Li JS (2012) Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry. Pediatrics 130:e1269\u2013e1277","journal-title":"Pediatrics"},{"key":"13208_CR6","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/bcp.14539","volume":"86","author":"RJ van Marum","year":"2020","unstructured":"van Marum RJ (2020) Underrepresentation of the elderly in clinical trials, time for action. Br J Clin Pharmacol 86:2014\u20132016","journal-title":"Br J Clin Pharmacol"},{"key":"13208_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41593-024-01608-4","volume":"27","author":"C Cardenas-Iniguez","year":"2024","unstructured":"Cardenas-Iniguez C, Gonzalez MR (2024) Recommendations for the responsible use and communication of race and ethnicity in neuroimaging research. Nat Neurosci 27:615\u2013628","journal-title":"Nat Neurosci"},{"key":"13208_CR8","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1056\/NEJMp2215609","volume":"388","author":"AL Schwartz","year":"2023","unstructured":"Schwartz AL, Alsan M, Morris AA, Halpern SD (2023) Why diverse clinical trial participation matters. N Engl J Med 388:1252\u20131254","journal-title":"N Engl J Med"},{"key":"13208_CR9","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ICH harmonised tripartite guideline studies in support of special populations: geriatrics E7 Current Step 4 version; 1993."},{"key":"13208_CR10","unstructured":"Inclusion of women and minorities as participants in research involving human subjects|Grants & Funding. https:\/\/grants.nih.gov\/policy-and-compliance\/policy-topics\/inclusion\/women-and-minorities."},{"key":"13208_CR11","unstructured":"NOT-OD-18\u2013014: Revision: NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research. https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/NOT-OD-18-014.html."},{"key":"13208_CR12","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1210\/clinem\/dgab434","volume":"106","author":"J White","year":"2021","unstructured":"White J, Tannenbaum C, Klinge I, Schiebinger L, Clayton J (2021) The integration of sex and gender considerations into biomedical research: lessons from international funding agencies. J Clin Endocrinol Metab 106:3034\u20133048","journal-title":"J Clin Endocrinol Metab"},{"key":"13208_CR13","unstructured":"Federal Register: Revisions to OMB\u2019s statistical policy directive No. 15: standards for maintaining, collecting, and presenting federal data on race and ethnicity. https:\/\/www.federalregister.gov\/documents\/2024\/03\/29\/2024-06469\/revisions-to-ombs-statistical-policy-directive-no-15-standards-for-maintaining-collecting-and."},{"key":"13208_CR14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jamaneurol.2022.2808","volume":"79","author":"NC Porter","year":"2022","unstructured":"Porter NC, Morgenstern LB (2022) Racial and ethnic equity in neuromuscular care-time for our action to live up to potential. JAMA Neurol 79:1221\u20131222","journal-title":"JAMA Neurol"},{"key":"13208_CR15","doi-asserted-by":"publisher","unstructured":"Oksanen, J. et al. Community ecology package [R package vegan version 2.6\u201310]. CRAN: Contributed Packages; 2025. https:\/\/doi.org\/10.32614\/CRAN.PACKAGE.VEGAN.","DOI":"10.32614\/CRAN.PACKAGE.VEGAN"},{"key":"13208_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v058.i03","volume":"58","author":"R Killick","year":"2014","unstructured":"Killick R, Eckley IA (2014) changepoint: an R package for changepoint analysis. J Stat Softw 58:1\u201319","journal-title":"J Stat Softw"},{"key":"13208_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","volume":"7","author":"PA McCombe","year":"2010","unstructured":"McCombe PA, Henderson RD (2010) Effects of gender in amyotrophic lateral sclerosis. Gend Med 7:557\u2013570","journal-title":"Gend Med"},{"key":"13208_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000494291","volume":"52","author":"MC Broers","year":"2019","unstructured":"Broers MC, Bunschoten C, Nieboer D, Lingsma HF, Jacobs BC (2019) Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiology 52:161\u2013172","journal-title":"Neuroepidemiology"},{"key":"13208_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029240","volume":"9","author":"A Theadom","year":"2019","unstructured":"Theadom A et al (2019) Prevalence of Charcot-Marie-Tooth disease across the lifespan: a population-based epidemiological study. BMJ Open 9:e029240","journal-title":"BMJ Open"},{"key":"13208_CR20","volume":"18","author":"Z Wang","year":"2021","unstructured":"Wang Z et al (2021) Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study. Lancet Reg Health West Pac 18:100323","journal-title":"Lancet Reg Health West Pac"},{"key":"13208_CR21","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung H-P (2012) Guillain-Barr\u00e9 syndrome. N Engl J Med 366:2294\u20132304","journal-title":"N Engl J Med"},{"key":"13208_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/mus.24562","volume":"52","author":"AD Paltiel","year":"2015","unstructured":"Paltiel AD et al (2015) Demographic and clinical features of inclusion body myositis in North America. Muscle Nerve 52:527\u2013533","journal-title":"Muscle Nerve"},{"key":"13208_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ncl.2014.04.001","volume":"32","author":"MM Dimachkie","year":"2014","unstructured":"Dimachkie MM, Barohn RJ (2014) Inclusion body myositis. Neurol Clin 32:629\u2013646","journal-title":"Neurol Clin"},{"key":"13208_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/cen3.12326","volume":"7","author":"M Motomura","year":"2016","unstructured":"Motomura M, Nakata R, Shiraishi H (2016) Lambert-Eaton myasthenic syndrome: clinical review. Clin Exp Neuroimmunol 7:238\u2013245","journal-title":"Clin Exp Neuroimmunol"},{"key":"13208_CR25","doi-asserted-by":"publisher","DOI":"10.1159\/000539577\/914586\/PREVALENCE-INCIDENCE-AND-MORTALITY-OF-MYASTHENIA","author":"F Sciancalepore","year":"2024","unstructured":"Sciancalepore F et al (2024) Prevalence, incidence, and mortality of myasthenia gravis and myasthenic syndromes: a systematic review. Neuroepidemiology. https:\/\/doi.org\/10.1159\/000539577\/914586\/PREVALENCE-INCIDENCE-AND-MORTALITY-OF-MYASTHENIA","journal-title":"Neuroepidemiology"},{"key":"13208_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(05)71337-4","volume":"357","author":"K Poulas","year":"2001","unstructured":"Poulas K, Tzartos SJ (2001) The gender gap in autoimmune disease. Lancet 357:234","journal-title":"Lancet"},{"key":"13208_CR27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/healthcare12080838","volume":"12","author":"L Hern\u00e1ez","year":"2024","unstructured":"Hern\u00e1ez L et al (2024) Prevalence of Steinert\u2019s myotonic dystrophy and utilization of healthcare services: a population-based cross-sectional study. Healthcare (Basel) 12:838","journal-title":"Healthcare (Basel)"},{"key":"13208_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000444018","volume":"46","author":"N Vanacore","year":"2016","unstructured":"Vanacore N et al (2016) An age-standardized prevalence estimate and a sex and age distribution of myotonic dystrophy types 1 and 2 in the Rome province. Italy Neuroepidemiology 46:191\u2013197","journal-title":"Italy Neuroepidemiology"},{"key":"13208_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1590\/S0482-50042011000500003","volume":"51","author":"FH Souza","year":"2011","unstructured":"Souza FH, Levy-Neto M, Shinjo SK (2011) Prevalence of clinical and laboratory manifestations and comorbidities in polymyositis according to gender. Rev Bras Reumatol 51:428\u2013483","journal-title":"Rev Bras Reumatol"},{"key":"13208_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1756-185X.2010.01472.x","volume":"13","author":"S Cox","year":"2010","unstructured":"Cox S, Limaye V, Hill C, Blumbergs P, Roberts-Thomson P (2010) Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis 13:117\u2013124","journal-title":"Int J Rheum Dis"},{"key":"13208_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/cpt.61","volume":"97","author":"A Ramamoorthy","year":"2015","unstructured":"Ramamoorthy A, Pacanowski MA, Bull J, Zhang L (2015) Racial\/ethnic differences in drug disposition and response: review of recently approved drugs. Clin Pharmacol Ther 97:263\u2013273","journal-title":"Clin Pharmacol Ther"},{"key":"13208_CR32","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1212\/WNL.0000000000203257","volume":"100","author":"B Beland","year":"2023","unstructured":"Beland B, Jewett G, Lee A, Perera T, Korngut L (2023) Sex differences in therapy for myasthenia gravis (P7\u20138.002). Neurology 100:3421","journal-title":"Neurology"},{"key":"13208_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111793","volume":"211","author":"C Vinciguerra","year":"2023","unstructured":"Vinciguerra C et al (2023) Sex differences in neuromuscular disorders. Mech Ageing Dev 211:111793","journal-title":"Mech Ageing Dev"},{"key":"13208_CR34","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JND-230011","volume":"10","author":"J Sun","year":"2023","unstructured":"Sun J, Harrington MA, Porter B (2023) Sex difference in spinal muscular atrophy patients\u2014are males more vulnerable? J Neuromuscul Dis 10:847\u2013867","journal-title":"J Neuromuscul Dis"},{"key":"13208_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fgene.2020.00054","volume":"11","author":"E Vorster","year":"2020","unstructured":"Vorster E, Essop FB, Rodda JL, Krause A (2020) Spinal muscular atrophy in the black South African population: a matter of rearrangement? Front Genet 11:54","journal-title":"Front Genet"},{"key":"13208_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102228","volume":"95","author":"A Zamani","year":"2024","unstructured":"Zamani A, Thomas E, Wright DK (2024) Sex biology in amyotrophic lateral sclerosis. Ageing Res Rev 95:102228","journal-title":"Ageing Res Rev"},{"key":"13208_CR37","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1212\/WNL.0000000000003298","volume":"87","author":"AL Roberts","year":"2016","unstructured":"Roberts AL, Johnson NJ, Chen JT, Cudkowicz ME, Weisskopf MG (2016) Race\/ethnicity, socioeconomic status, and ALS mortality in the United States. Neurology 87:2300\u20132308","journal-title":"Neurology"},{"key":"13208_CR38","volume":"2015","author":"F Abukhalil","year":"2015","unstructured":"Abukhalil F, Mehta B, Saito E, Mehta S, McMurtray A (2015) Gender and ethnicity based differences in clinical and laboratory features of myasthenia gravis. Autoimmune Dis 2015:197893","journal-title":"Autoimmune Dis"},{"key":"13208_CR39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/mus.27331","volume":"64","author":"JLS Thomsen","year":"2021","unstructured":"Thomsen JLS, Vinge L, Harbo T, Andersen H (2021) Gender differences in clinical outcomes in myasthenia gravis: a prospective cohort study. Muscle Nerve 64:538\u2013544","journal-title":"Muscle Nerve"},{"key":"13208_CR40","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/mus.21191","volume":"39","author":"SJ Oh","year":"2009","unstructured":"Oh SJ et al (2009) Racial differences in myasthenia gravis in Alabama. Muscle Nerve 39:328\u2013332","journal-title":"Muscle Nerve"},{"key":"13208_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13023-024-03209-7","volume":"19","author":"NL Crossnohere","year":"2024","unstructured":"Crossnohere NL et al (2024) Barriers to diverse clinical trial participation in Duchenne muscular dystrophy: engaging Hispanic\/Latina caregivers and health professionals. Orphanet J Rare Dis 19:207","journal-title":"Orphanet J Rare Dis"},{"key":"13208_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148264","volume":"11","author":"C Dogan","year":"2016","unstructured":"Dogan C et al (2016) Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study. PLoS ONE 11:e0148264","journal-title":"PLoS ONE"},{"key":"13208_CR43","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJMe2114651","volume":"385","author":"E Rubin","year":"2021","unstructured":"Rubin E (2021) Striving for diversity in research studies. N Engl J Med 385:1429\u20131430","journal-title":"N Engl J Med"},{"key":"13208_CR44","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41586-023-06382-0","volume":"620","author":"MA Velez","year":"2023","unstructured":"Velez MA et al (2023) Consent document translation expense hinders inclusive clinical trial enrolment. Nature 620:855\u2013862","journal-title":"Nature"},{"key":"13208_CR45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/mus.28344","volume":"71","author":"G Vadi","year":"2025","unstructured":"Vadi G et al (2025) Pregnancy in the era of disease-modifying therapies for spinal muscular atrophy: considerations from a case report. Muscle Nerve 71:685\u2013687","journal-title":"Muscle Nerve"},{"key":"13208_CR46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0960-8966(02)00213-4","volume":"13","author":"K Bushby","year":"2003","unstructured":"Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th\u20139th June 2002, Naarden, the Netherlands. Neuromusc Disord 13:166\u2013172","journal-title":"Neuromusc Disord"},{"key":"13208_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jns.2013.09.036","volume":"336","author":"F Giliberto","year":"2014","unstructured":"Giliberto F et al (2014) Symptomatic female carriers of Duchenne muscular dystrophy (DMD): genetic and clinical characterization. J Neurol Sci 336:36\u201341","journal-title":"J Neurol Sci"},{"issue":"Pt 8","key":"13208_CR48","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/brain\/121.8.1557","volume":"121","author":"CEM De Die-Smulders","year":"1998","unstructured":"De Die-Smulders CEM et al (1998) Age and causes of death in adult-onset myotonic dystrophy. Brain 121(Pt 8):1557\u20131563","journal-title":"Brain"},{"key":"13208_CR49","doi-asserted-by":"publisher","first-page":"E2304","DOI":"10.1212\/WNL.0000000000012910","volume":"97","author":"J Broomfield","year":"2021","unstructured":"Broomfield J, Hill M, Guglieri M, Crowther M, Abrams K (2021) Life expectancy in duchenne muscular dystrophy: reproduced individual patient data meta-analysis. Neurology 97:E2304\u2013E2314","journal-title":"Neurology"},{"key":"13208_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/ENE.16103","author":"L Fontanelli","year":"2023","unstructured":"Fontanelli L, Di Rauso G, Bellini G (2023) Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven? Eur J Neurol. https:\/\/doi.org\/10.1111\/ENE.16103","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13208-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:40:39Z","timestamp":1757209239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13208-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["13208"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13208-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was conducted using publicly available data and did not involve human participants; as such, ethical approval, patient consent, and institutional review board IRB approval were not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"483"}}